Topical Tretinoin effective in nail psoriasis

Due to predominant distal nail bed disease, reluctance for injectable therapy, high cost and poor availability of tazarotene, topical tretinoin 0.025% cream was prescribed. After approximately 3 months of regular application, an almost complete resolution of nail changes was seen with NAPSI at week 12 of the therapy dropping down to 5. The patient reported no major adverse effects. Then the frequency of the application was reduced to alternate nights and then to twice a week. There has been no exacerbation over further 6 months of follow‑up.

Nail psoriasis has a tremendous impact on the quality of life. Management of isolated nail psoriasis depends on the severity of nail involvement and the impact of the disease on quality of life. The treatment options include topical, intralesional or systemic medications. Systemic therapy is recommended for multiple nail involvement, severe nail disease or severe impact on quality of life. The most commonly used therapy has been topical corticosteroids, with or without vitamin D analogues.

Topical retinoids are a useful steroid‑free alternative in a wide range of dermatological diseases. The antiproliferative, differentiation normalizing, and anti‑inflammatory effects of retinoids are the reason for their use in psoriasis. Tretinoin is easily available and cost‑effective compared to tazarotene. Its preliminary use in our patient showed excellent response within 6 weeks, encouraging us to further extend the treatment duration. Though the use of tazarotene as a topical treatment for nail psoriasis is well known, that of topical tretinoin has not been reported.

To conclude topical tretinoin cream can be a simple, cost‑effective, and easily available retinoid for topical treatment of nail psoriasis, especially with distal nail disease.

Source-

1. Grover C, Daulatabad D. Topical tretinoin in the treatment of nail psoriasis. Indian Dermatol Online J 2022;13:126-7.

2. Dogra A, Arora AK. Nail psoriasis: the journey so far. Indian J Dermatol. 2014 Jul;59(4):319-33. doi: 10.4103/0019-5154.135470.